Cargando…

PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment

Detalles Bibliográficos
Autores principales:	Grenga, Italia, Donahue, Renee N, Lepone, Lauren, Bame, Jessa, Schlom, Jeffrey, Farsaci, Benedetto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288383/ http://dx.doi.org/10.1186/2051-1426-2-S3-P102

Ejemplares similares

PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
por: Lepone, Lauren, et al.
Publicado: (2014)

Effects of tyrosine kinase inhibitors alone or in combination with vaccine on tumor-infiltrating myeloid cells
por: Donahue, Renee N, et al.
Publicado: (2013)

Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)
por: Donahue, Renee N, et al.
Publicado: (2014)

Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression
por: Grenga, Italia, et al.
Publicado: (2015)

Tumor vascular normalization as a strategy to potentiate effectiveness of therapeutic vaccines
por: Farsaci, Benedetto, et al.
Publicado: (2014)

Flow-cytometry phenotypic assessment of immune cell subsets reflecting function for the identification of breast cancer patients receiving vaccine plus docetaxel with longer progression-free survival
por: Grenga, Italia, et al.
Publicado: (2013)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine
por: Farsaci, Benedetto, et al.
Publicado: (2013)

A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses
por: Grenga, Italia, et al.
Publicado: (2016)

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
por: Lepone, Lauren, et al.
Publicado: (2015)

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
por: Heery, Christopher R, et al.
Publicado: (2015)

Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
por: Donahue, Renee N., et al.
Publicado: (2017)

Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack
por: Grenga, Italia, et al.
Publicado: (2015)

Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types
por: Lepone, Lauren M., et al.
Publicado: (2016)

Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor
por: Vandeveer, Amanda, et al.
Publicado: (2015)

Protective role of interferon gamma in murine antigen-induced arthritis
por: Hückel, M, et al.
Publicado: (2004)

Interferon-gamma reverses sepsis-induced immunoparalysis of monocytes in vitro
por: Mouktaroudi, M, et al.
Publicado: (2010)

Effect of interferon gamma on sepsis-related death in patients with immunoparalysis
por: Takeyama, N, et al.
Publicado: (2004)

The value of interferon-gamma blood tests for the diagnosis of tuberculosis in HIV patients
por: Căliman-Sturdza, Olga Adriana, et al.
Publicado: (2013)

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
por: Jochems, Caroline, et al.
Publicado: (2016)

Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model
por: Lyon, Amanda, et al.
Publicado: (2014)

Neuronal MHC-I display in T-cell mediated neurodegeneration
por: Cebrián, Carolina, et al.
Publicado: (2013)

Characterisation and culture of primary human nasal epithelial cells and the influence of Interferon-gamma
por: Waltl, Eva, et al.
Publicado: (2014)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody
por: Boyerinas, Benjamin, et al.
Publicado: (2014)

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
por: Smith, Andressa A, et al.
Publicado: (2013)

T-cell receptor-independent induction of interferon gamma expression in human memory Th cells
por: Sattler, A
Publicado: (2005)

Therapeutic neutralization of interferon-gamma in primates prevents lethality in Gram-negative bacteremic shock
por: Lainée, P, et al.
Publicado: (2004)

Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue
por: Doppler, W, et al.
Publicado: (2005)

Post-operative immune suppression is reversible with interferon gamma and independent of IL-6 pathways
por: Longbottom, ER, et al.
Publicado: (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer
por: Woods, Katherine, et al.
Publicado: (2015)

Interferon gamma levels are reduced by adenosine 5'-triphosphate in lipopolysaccharide-stimulated whole human blood
por: Nalos, M, et al.
Publicado: (2007)

Positive predictive value of Interferon-gamma release assay for incident active tuberculosis in HIV-infected persons
por: Lee, Susan Shin-Jung, et al.
Publicado: (2012)

Designing of interferon-gamma inducing MHC class-II binders
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2013)

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure
por: Shin, Daniel, et al.
Publicado: (2015)

Effects of conventional therapeutic interventions on the number and function of regulatory T cells
por: Roselli, Mario, et al.
Publicado: (2013)

A porcine model of hydrocephalus induced by gamma knife irradiation
por: Duncan, John, et al.
Publicado: (2009)

Interferon (IFNγ) induces cell cycle arrest in RCC cell lines
por: Tate, David J, et al.
Publicado: (2013)

Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015)

The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
por: David, Justin, et al.
Publicado: (2014)

Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC class I antibodies
por: Vlaar, AP, et al.
Publicado: (2010)

PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
por: Sanchez-Manubens, J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ifd2qhbhjpupq7t0g12u5c7has